PMEL and cancer: The 12MP and 6MHP vaccines target shared melanoma antigens, including both melanocytic differentiation proteins (MDPs: gp100, tyrosinase, and MART-1/MelanA) and cancer-testis antigens (CTAs: MAGE antigens and NY-ESO-1).